Motilal Oswal's research report on Repco Home Finance
Repco Home Finance (REPCO)’s 2QFY25 PAT grew 15% YoY to INR1.1b (in line). The company’s 1HFY25 PAT grew ~16% YoY to ~INR2.2b, and we expect 2HFY25 PAT to increase ~7% YoY. The NII declined ~2% YoY to ~INR1.7b (in line). REPCO reported a healthy growth in its other income, primarily led by improvements in insurance commissions, investment income, and recoveries from written-off accounts. Opex rose ~21% YoY to INR517m (~10% above MOFSLe) due to higher depreciation, which would normalize from next quarter onwards. Provision write-backs for 2Q stood at ~INR160m, translating into annualized credit costs of -45bp (PY: ~5bp and PQ: ~4bp). GNPA declined ~30bp QoQ to ~4%, while NNPA dipped ~5bp QoQ to ~1.7%. The company reduced the PCR on S3 loans by ~1pp QoQ to ~61%.
Outlook
We cut our FY26/FY27 estimates by ~5% each to factor in lower loan growth and normalization in credit costs. We model a loan/PAT CAGR of ~10%/8% over FY24-FY27E. For an RoA/RoE of 2.8%/12.4% in FY27E, we reiterate our Neutral rating on the stock with our revised TP of INR500 (based on 0.8x Sep’26E BVPS).
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
